ÈÑÒÈÍÀ

Rose-John Stefan

Ñîàâòîðû: Scheller J., Íåäîñïàñîâ Ñ.À., Êðóãëîâ À.À., Plagmann I., Øâàðåâ Ä.Ñ., Sack M., Ãîðÿéíîâà Î.Ñ., Stacey M., Rosenstiel P., Òèëëèá Ñ.Â., Gordon S., Floss D.M., Malchow S. ïîêàçàòü ïîëíîñòüþ..., Efimov G.A., Chalaris A., Conrad U.

2 ñòàòüè, 1 òåçèñû äîêëàäà

Êîëè÷åñòâî öèòèðîâàíèé ñòàòåé â æóðíàëàõ ïî äàííûì Scopus: 38, Web of Science: 39

IstinaResearcherID (IRID): 464628

Äåÿòåëüíîñòü ñòèëü:  îáû÷íûé | ÃÎÑÒ | plain | abbrv | acm | alpha | amsalpha | amsplain | apalike | ieeetr | siam

• Ñòàòüè â æóðíàëàõ

  • 
    • 2011 ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock
    • Conrad Udo, Plagmann Ingo, Malchow Sven, Sack Markus, Floss Doreen M., Kruglov Andrei A., Nedospasov Sergei A., Rose-John Stefan, Scheller Juergen
    • â æóðíàëå Plant Biotechnology Journal, èçäàòåëüñòâî Blackwell Publishing Inc. (United Kingdom), òîì 9, ? 1, ñ. 22-31 DOI
  • 
    • 2009 Transglutaminase-catalyzed covalent multimerization of Camelidae anti-human TNF single domain antibodies improves neutralizing activity
    • Plagmann I., Chalaris A., Kruglov AA, Nedospasov S., Rosenstiel P., Rose-John S., Scheller J.
    • â æóðíàëå Journal of Biotechnology, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 142, ? 2, ñ. 170-178 DOI

• Òåçèñû äîêëàäîâ

  • • 2015 Cell type-restricted cytokine inhibition by bispecific antibodies
    • Efimov G.A., Tillib S.V., Shvarev D.S., Goriainova O.S., Gordon S., Stacey M., Rose-John S., Scheller J., Kruglov A.A., Nedospasov S.A.
    • â ñáîðíèêå Antibodies as Drugs: Immunological Scaffolds as Therapeutics, ìåñòî èçäàíèÿ Canada, òåçèñû